Figure 3
From: Expression analysis and implication of Rab1A in gastrointestinal relevant tumor
Prognostic relevance of Rab1A overexpression in gastrointestinal cancers. (A) The overall survival (OS) of esophageal carcinoma (ESCA), stomach adenocarcinoma (STAD), colon adenocarcinoma (COAD), rectum adenocarcinoma (READ), liver hepatocellular carcinoma (LIHC), cholangio carcinoma (CHOL) and pancreatic adenocarcinoma (PAAD) patients classified on the basis of Rab1A expression. (B) Rab1A expression in the paired tumor and healthy tissues in GC patients. (C) OS of Rab1Ahi and Rab1Alo GC patients.
